메뉴 건너뛰기




Volumn 33, Issue 7, 2009, Pages 68-73

Next-generation facilities for monoclonal antibody production

Author keywords

[No Author keywords available]

Indexed keywords

BIOPHARMACEUTICAL INDUSTRY; CELL LINES; MONOCLONAL ANTIBODY PRODUCTION;

EID: 77952080884     PISSN: 15432521     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (11)

References (10)
  • 1
    • 77952028473 scopus 로고    scopus 로고
    • Pharmaceutical Research and Manufacturers of America Biotechnology Research Continues to Bolster Arsenal Against Disease with 633 Medicines in Development accessed June 1, 2009
    • Pharmaceutical Research and Manufacturers of America, "Biotechnology Research Continues to Bolster Arsenal Against Disease with 633 Medicines in Development," phrma.org/medicines-in-development-for-biotechnology/, accessed June 1,2009.
  • 4
    • 77952063972 scopus 로고    scopus 로고
    • Proactive debottlenecking: Planning ahead for the downstream bottleneck
    • C. Schott, "Proactive Debottlenecking: Planning Ahead for the Downstream Bottleneck," BioProcess Int. 6 (9), 18-23 (2008).
    • (2008) BioProcess Int. , vol.6 , Issue.9 , pp. 18-23
    • Schott, C.1
  • 5
    • 77952049172 scopus 로고    scopus 로고
    • How do we get to 30g/l using fed-batch technology? what are the limitations?
    • presented at IBC's Carlsbad, CA
    • T. Ryll, "How Do We Get to 30g/L using Fed-Batch Technology? What are the Limitations?" presented at IBC's 22nd International Antibody Development & Production Conference, Carlsbad, CA, 2009.
    • (2009) 22nd International Antibody Development & Production Conference
    • Ryll, T.1
  • 7
    • 45149110469 scopus 로고    scopus 로고
    • Bioseparation in antibody manufacturing: The good, the bad, and the ugly
    • U. Gottschalk, "Bioseparation in Antibody Manufacturing: The Good, The Bad, and The Ugly," Biotechnol. Prog. 24 (3), 496-1453, (2008).
    • (2008) Biotechnol. Prog. , vol.24 , Issue.3 , pp. 496-1453
    • Gottschalk, U.1
  • 8
    • 77952076835 scopus 로고    scopus 로고
    • Where is biopharmaceutical manufacturing heading?"
    • G. Jagschies, "Where is Biopharmaceutical Manufacturing Heading?" Biopharm Int. 23 (10), 16-22 (2009).
    • (2009) Biopharm Int. , vol.23 , Issue.10 , pp. 16-22
    • Jagschies, G.1
  • 9
    • 77952083134 scopus 로고    scopus 로고
    • Environmental impact of single use and reusable bioprocess systems
    • B. Rawlings and H. Pora, "Environmental Impact of Single Use and Reusable Bioprocess systems," BioProcess Int. 7 (2), 18-26 (2009).
    • (2009) BioProcess Int. , vol.7 , Issue.2 , pp. 18-26
    • Rawlings, B.1    Pora, H.2
  • 10
    • 77149132767 scopus 로고    scopus 로고
    • Environmental life-cycle assessment of disposable bioreactors
    • M. Mauter, "Environmental Life-Cycle Assessment of Disposable Bioreactors," BioProcess Int. 8 (4), 18-28 (2009).
    • (2009) BioProcess Int. , vol.8 , Issue.4 , pp. 18-28
    • Mauter, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.